Tag archive for ‘Science and technology in Israel’
Jewish Business News On Thursday, October 1st, 2015

Teva acquires Mexican Rimsa pharmaceutical for $2.3 billion

  Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) is acquiring Rimsa,  an independent pharmaceutical company in Mexico with a portfolio of products and patents in Latin America and Europe More...

Jewish Business News On Thursday, October 1st, 2015

Second time in a row: Technion team wins a gold medal in the international iGEM competition

  The Technion team has won a gold medal in the international iGEM competition for the second year in a row. In addition to the medal, the team won the following: first place for Best New Application, More...

JNS On Wednesday, September 16th, 2015

Israeli universities slip slightly in global ranking

    Israel’s Ben-Gurion University of the Negev, Bar-Ilan University, and Tel Aviv University all rose from the previous year in the prestigious QS World University Rankings for 2015-16, published More...

Niva Goldberg On Monday, August 17th, 2015

Hebrew University ranked Israel’s top among the world’s elite universities

  According to annual Academic Ranking of World Universities (ARWU) for 2015, released by Shanghai Jiao Tong University, the Hebrew University of Jerusalem is Israel’s leading academic institution, More...

John Rampton On Monday, July 27th, 2015

Israel’s Hot Startup Scene is Fostering Several Unicorns

  I recently had the privilege to fly from Silicon Valley to what many know as Silicon Wadi (also know as Tel Aviv, Israel). Israel has more that 6, 000 startups and attracts more venture capital More...

Shiri Habib-Valdhorn On Monday, July 27th, 2015

Three Way Takeover Battle – The End: Teva losing $300 million on Mylan stake

  Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has officially announced that it is withdrawing its bid to buy generic pharmaceuticals rival Mylan N.V. after agreeing to buy Allergan Generics More...

Niva Goldberg On Tuesday, July 7th, 2015

Three Way Takeover Battle: Teva plans raising Mylan bid to $43 billion – report

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA), the Israeli drugmaker, is preparing to improved proposal for US rival Mylan to as much as $43 billion, $86 to $88 a share, as soon as this More...

Shiri Habib-Valdhorn On Wednesday, July 1st, 2015

Teva CEO: The industry is undergoing a shakeup

“Size is important in the industry, but it isn’t everything. It’s important to be better. You have to make acquisitions that will suit the company’s strategic direction and contribute More...

Michael Ordman On Sunday, June 21st, 2015

Micro-antenna to treat gastro-cancer and more good news from israel

In the 21st Jun 2015 edition of Israel’s good news, the highlights include:   ·         Three important stomach-related medical developments from Israeli scientists. ·         Israeli experts More...

Three Way Takeover Battle: Teva Completes the Purchase of 4.61 Percent Interest in Mylan N.V.

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) has completed first step to buy its rival Mylan N.V. (Nasdaq: MYL). The Israeli giant announced on Friday that it has completed the purchase of a 4.61% More...

Wordpress site Developed by Fixing WordPress Problems